Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,712 public trials 267 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

NCT01192867

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: K&S Professional Research Services LLC Little Rock, Arkansas, United States

Advanced Research Center Inc. Anaheim, California, United States

Comprehensive Clinical Development- Cerritos CA Cerritos, California, United States

Diligent Clinical Trials Inc Downey, California, United States

View all 122 locations

View Trial Details

Completed

Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile

NCT03197168

Conditions: Behavior, Bipolar Disorder, Bipolar and Related Disorders, +8 more
Locations: University of Chile Santiago, Santiago Metropolitan, Chile

View Trial Details

Completed

Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects

NCT01090440

Conditions: Depressive Disorder, Mental Disorders, Mood Disorders, +2 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.

NCT01955564

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Collaborative Neuroscience Network-Clinical Pharmacology Unit Long Beach, California, United States

View Trial Details

Completed

A Repeat Dose Positron Emission Tomography Study With GSK1144814

NCT01209039

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: GSK Investigational Site Harrow, Middlesex, United Kingdom

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study

NCT01804257

Conditions: Behavior, Bipolar Disorder, Bipolar and Related Disorders, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Zucker Hillside Hospital Glen Oaks, New York, United States

View Trial Details

Completed

A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers

NCT01371799

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: GSK Investigational Site Cambridge, United Kingdom

View Trial Details

Completed

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

NCT01731119

Conditions: Asperger Syndrome, Autism Spectrum Disorder, Autistic Disorder, +18 more
Locations: University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Completed

Effects of Eszopiclone on Sleep and Memory in Schizophrenia

NCT01641900

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Past Pain Experience and Perception of Experimental Pain

NCT01575912

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depression, +8 more
Locations: Centre Hospitalier Esquirol Limoges, France

View Trial Details

Schizophrenia

Schizophrenia trial results

Related conditions